Inolimomab

Inolimomab is a mouse monoclonal antibody developed as an immunosuppressive drug against graft-versus-host disease. Its target is the alpha chain of the interleukin-2 receptor.

References

Retrieved from "https://en.wikipedia.org/w/index.php?title=Inolimomab&oldid=1169779105"

Uses material from the Wikipedia article Inolimomab, released under the CC BY-SA 4.0 license.